Repare Therapeutics
Biotechnology ResearchView the employees at
Repare Therapeutics-
Adisa Profka Accounting Analyst at Repare Therapeutics
-
Greater Montreal Metropolitan Area
-
Rising Star
Kristina Sforza Payroll and Accounting Manager at Repare Therapeutics-
Montreal, Quebec, Canada
-
Top 10%
Ayat Alsaraby, MSc, PMP Senior Manager, Clinical Biomarkers Operations at Repare Therapeutics-
Greater Boston
-
Top 5%
Sarsvat P. Quantitative Pharmacology, Clinical Pharmacology & Toxicology, Repare Therapeutics-
Rising Star
Overview
Repare Therapeutics (Nasdaq: RPTX) is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs. For more information, please visit www.reparerx.com.
-